+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Neurovascular Devices Market Report and Forecast 2023-2031

  • PDF Icon


  • 160 Pages
  • July 2023
  • Region: Global
  • Expert Market Research
  • ID: 5855144
The global neurovascular devices market attained a value of USD 3.2 billion in 2022, driven by the increase in incidences of neurological disorders such as brain, cerebral aneurysm, strokes, and epilepsy. The market is expected to grow at a CAGR of 7.85% during the forecast period of 2023-2031 to attain a value of USD 6.4 billion by 2031.

Neurovascular Devices: Introduction

Neurovascular devices are specialized medical devices used in the diagnosis, treatment, and management of neurological and vascular conditions affecting the brain and spinal cord. These devices are designed to address various neurovascular disorders, including ischemic and haemorrhagic strokes, aneurysms, arteriovenous malformations (AVMs), and other vascular abnormalities.

The benefits of neurovascular devices include:

  • Minimally Invasive Approach: Neurovascular devices enable minimally invasive procedures, reducing the need for open surgeries and associated risks. Minimally invasive interventions involve smaller incisions, shorter recovery times, and reduced post-operative complications, resulting in faster patient recovery and improved overall outcomes
  • Precise and Targeted Treatment: Neurovascular devices provide precise and targeted treatment options for neurovascular conditions. These devices can be navigated to the affected areas, allowing for focused interventions, and minimizing damage to surrounding healthy tissue
  • Improved Patient Outcomes: The use of neurovascular devices has led to improved patient outcomes in the management of neurovascular disorders. Timely and effective interventions using these devices can restore blood flow, reduce the risk of complications, and improve patient survival rates, functional outcomes, and quality of life
  • Expanded Treatment Options: Neurovascular devices have expanded treatment options for neurovascular disorders. They offer alternatives to traditional surgical approaches, allowing for less invasive procedures and providing options for patients who may not be suitable candidates for open surgeries
  • Enhanced Diagnostic Capabilities: Neurovascular devices aid in accurate diagnosis and assessment of neurovascular conditions. Advanced imaging systems and diagnostic devices enable healthcare professionals to obtain detailed information about blood vessel abnormalities, aiding in treatment planning and monitoring disease progression
It is important to note that the selection and use of specific neurovascular devices depend on the patient's condition, the expertise of healthcare professionals, and the availability of appropriate infrastructure and resources. Treatment decisions should be made in consultation with specialized neurovascular teams to ensure the most appropriate and effective use of these devices for individual patients.

Neurovascular Devices Market Segmentations

The market can be categorised into product type, disease, end user, and region.

Market Breakup by Product Type

  • Aneurysm Coiling and Embolization Devices
  • Cerebral Balloon Angioplasty and Stenting Systems
  • Support Devices
  • Neurothrombectomy Devices
  • Other Devices

Market Breakup by Disease

  • Ischemic Strokes
  • Cerebral Aneurysms
  • Arteriovenous Malformation and Fistulas
  • Other

Market Breakup by End User

  • Hospitals
  • Clinics
  • Home Healthcare
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Neurovascular Devices Market Overview

The market has witnessed substantial growth and is expected to continue expanding in the coming years. Several factors contribute to the positive market scenario.

One of the primary drivers of market growth is the increasing incidence of neurological disorders and vascular diseases affecting the brain and spinal cord. Conditions such as stroke, aneurysms, arteriovenous malformations (AVMs), and other neurovascular disorders require specialized devices for diagnosis, treatment, and management. The rising prevalence of these conditions, coupled with an aging population and lifestyle factors, contributes to the growing demand for neurovascular devices.

Moreover, advancements in technology and minimally invasive procedures have revolutionized the field of neurovascular interventions. Innovative devices such as stents, embolic coils, flow diverters, and catheters offer improved precision, safety, and efficacy in treating neurovascular diseases. These devices enable less invasive approaches, reduced procedure times, and enhanced patient outcomes, leading to increased adoption and market growth.

Furthermore, increasing awareness and initiatives focused on early detection and treatment of neurological conditions have contributed to market expansion. Efforts to improve access to healthcare services, establish comprehensive stroke centres, and promote public education on the signs and symptoms of stroke and other neurovascular diseases have led to greater demand for neurovascular devices.

Key Players in the Global Neurovascular Devices Market

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the neurovascular devices market are as follows:
  • Johnson & Johnson
  • Medtronic Plc
  • Stryker Corporation
  • Terumo Corporation
  • Penumbra
  • Braun Melsungen AG
  • Microport Scientific CorporatiON
*The publisher always strives to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Neurovascular Devices Market Overview
3.1 Global Neurovascular Devices Market Historical Value (2016-2022)
3.2 Global Neurovascular Devices Market Forecast Value (2023-2031)
4 Global Neurovascular Devices Market Dynamics
4.1 Market Drivers and Constraints
4.2 SWOT Analysis
4.3 Porter’s Five Forces Model
4.4 Key Demand Indicators
4.5 Key Price Indicators
4.6 Industry Events, Initiatives, and Trends
4.7 Value Chain Analysis
5 Global Neurovascular Devices Market Segmentation
5.1 Global Neurovascular Devices Market by Product Type
5.1.1 Market Overview
5.1.2 Aneurysm Coiling & Embolization Devices
5.1.3 Cerebral Balloon Angioplasty and Stenting Systems
5.1.4 Support Devices
5.1.5 Neurothrombectomy Devices
5.1.6 Others
5.2 Global Neurovascular Devices Market by Target Disease
5.2.1 Market Overview
5.2.2 Ischemic Strokes
5.2.3 Cerebral Aneurysms
5.2.4 Arteriovenous Malformartion, and Fistalus
5.2.5 Stenosis
5.2.6 Other target diseases
5.3 Global Neurovascular Devices Market by End User
5.3.1 Market Overview
5.3.2 Hospitals
5.3.3 Specialty Clinics
5.3.4 Others
5.4 Global Neurovascular Devices Market by Region
5.4.1 Market Overview
5.4.2 North America
5.4.3 Europe
5.4.4 Asia Pacific
5.4.5 Latin America
5.4.6 Middle East and Africa
6 North America Neurovascular Devices Market
6.1 Market Share by Country
6.2 United States of America
6.3 Canada
7 Europe Neurovascular Devices Market
7.1 Market Share by Country
7.2 United Kingdom
7.3 Germany
7.4 France
7.5 Italy
7.6 Others
8 Asia Pacific Neurovascular Devices Market
8.1 Market Share by Country
8.2 China
8.3 Japan
8.4 India
8.6 Australia
8.7 Others
9 Latin America Neurovascular Devices Market
9.1 Market Share by Country
9.2 Brazil
9.3 Argentina
9.4 Mexico
9.5 Others
10 Middle East and Africa Neurovascular Devices Market
10.1 Market Share by Country
10.2 Saudi Arabia
10.3 United Arab Emirates
10.4 Nigeria
10.5 South Africa
10.6 Others
11 Patent Analysis
11.1 Analysis by Type of Patent
11.2 Analysis by Publication year
11.3 Analysis by Issuing Authority
11.4 Analysis by Patent Age
11.5 Analysis by CPC Analysis
11.6 Analysis by Patent Valuation
11.7 Analysis by Key Players
12 Grants Analysis
12.1 Analysis by year
12.2 Analysis by Amount Awarded
12.3 Analysis by Issuing Authority
12.4 Analysis by Grant Application
12.5 Analysis by Funding Institute
12.6 Analysis by NIH Departments
12.7 Analysis by Recipient Organization
13 Funding Analysis
13.1 Analysis by Funding Instances
13.2 Analysis by Type of Funding
13.3 Analysis by Funding Amount
13.4 Analysis by Leading Players
13.5 Analysis by Leading Investors
13.6 Analysis by Geography
14 Partnership and Collaborations Analysis
14.1 Analysis by Partnership Instances
14.2 Analysis by Type of Partnership
14.3 Analysis by Leading Players
14.4 Analysis by Geography
15 Regulatory Framework
15.1 Regulatory Overview
15.1.1 US FDA
15.1.2 EU EMA
15.1.5 Others
16 Supplier Landscape
16.1 Medtronic
16.1.1 Financial Analysis
16.1.2 Product Portfolio
16.1.3 Demographic Reach and Achievements
16.1.4 Mergers and Acquisitions
16.1.5 Certifications
16.2 Penumbra
16.2.1 Financial Analysis
16.2.2 Product Portfolio
16.2.3 Demographic Reach and Achievements
16.2.4 Mergers and Acquisitions
16.2.5 Certifications
16.3 Stryker
16.3.1 Financial Analysis
16.3.2 Product Portfolio
16.3.3 Demographic Reach and Achievements
16.3.4 Mergers and Acquisitions
16.3.5 Certifications
16.4 Johnson & Johnson Services, Inc.
16.4.1 Financial Analysis
16.4.2 Financial Portfolio
16.4.3 Demographic Reach and Achievements
16.4.4 Mergers and Acquisitions
16.4.5 Certifications
16.5 MicroPort Scientific Corporation
16.5.1 Financial Analysis
16.5.2 Product Portfolio
16.5.3 Demographic Reach and Achievements
16.5.4 Mergers and Acquisitions
16.5.5 Certifications
16.6 Acandis GmbH
16.6.1 Financial Analysis
16.6.2 Product Portfolio
16.6.3 Demographic Reach and Achievements
16.6.4 Mergers and Acquisitions
16.6.5 Certifications
16.7 MicroVention Inc.
16.7.1 Financial Analysis
16.7.2 Product Portfolio
16.7.3 Demographic Reach and Achievements
16.7.4 Mergers and Acquisitions
16.7.5 Certifications
16.8 NeuroVasc Technologies, Inc.
16.8.1 Financial Analysis
16.8.2 Product Portfolio
16.8.3 Demographic Reach and Achievements
16.8.4 Mergers and Acquisitions
16.8.5 Certifications
16.9.1 Financial Analysis
16.9.2 Product Portfolio
16.9.3 Demographic Reach and Achievements
16.9.4 Mergers and Acquisitions
16.9.5 Certifications
16.10 Perflow Medical Ltd.
16.10.1 Financial Analysis
16.10.2 Product Portfolio
16.10.3 Demographic Reach and Achievements
16.10.4 Mergers and Acquisitions
16.10.5 Certifications
16.11 Medikit co., ltd
16.11.1 Financial Analysis
16.11.2 Product Portfolio
16.11.3 Demographic Reach and Achievements
16.11.4 Mergers and Acquisitions
16.11.5 Certifications
16.12 Lepu Medical Technology (Beijing) Co. Ltd.
16.12.1 Financial Analysis
16.12.2 Product Portfolio
16.12.3 Demographic Reach and Achievements
16.12.4 Mergers and Acquisitions
16.12.5 Certifications
16.13 Terumo Corporation
16.13.1 Financial Analysis
16.13.2 Product Portfolio
16.13.3 Demographic Reach and Achievements
16.13.4 Mergers and Acquisitions
16.13.5 Certifications
17 Global Neurovascular Devices Market - Distribution Model (Additional Insight)
17.1 Overview
17.2 Potential Distributors
17.3 Key Parameters for Distribution Partner Assessment
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
  • *Additional insights provided are customisable as per client requirements.

Companies Mentioned

  • Johnson & Johnson
  • Medtronic Plc
  • Stryker Corporation
  • Terumo Corporation
  • Penumbra
  • Acandis GmbH
  • Braun Melsungen AG
  • Integer Holdings Corporation
  • Microport Scientific CorporatiON



Table Information